Wordt geladen...
Prostate cancer: endogenous chemical castration
We report treatment of intermediate risk prostate cancer in a patient with a brief period of androgen deprivation secondary to a pituitary adenoma. This was a patient with intermediate risk prostate cancer diagnosed in the setting of an elevated prostate-specific antigen (PSA). The patient subsequen...
Bewaard in:
| Gepubliceerd in: | BMJ Case Rep |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854128/ https://ncbi.nlm.nih.gov/pubmed/27126094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-214782 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|